# Prospective Clinical Study to Identify Secondary Sentinel Lymph Nodes in Patients With N1/N2b Oral Cavity or H&N Skin Cancers Using Patent Blue V and Indocyanine Green Dyes

> **NCT07518485** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 20 (estimated)

## Conditions studied

- N1/N2b Oral Cavity Cancer
- Head and Neck Skin Cancer

## Interventions

- **DRUG:** Patent blue V dye injection
- **DRUG:** Indocyanine green dye injection

## Key facts

- **NCT ID:** NCT07518485
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-03
- **Final completion:** 2027-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07518485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07518485, "Prospective Clinical Study to Identify Secondary Sentinel Lymph Nodes in Patients With N1/N2b Oral Cavity or H&N Skin Cancers Using Patent Blue V and Indocyanine Green Dyes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07518485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*